Non-Surgical Vaginal Rejuvenation: Every Treatment, Who It's For, and What It Really Costs
Non-surgical vaginal rejuvenation treats thin, dry, painful or lax vaginal tissue without surgery or ablative lasers. The main options are vaginal PRP (your own platelets placed in the vaginal wall), red and near-infrared light, medical ozone, and hormone therapy guided by bloodwork. At Velva, light therapy starts at $100 a session and vaginal PRP is $2,200.
What Non-Surgical Vaginal Rejuvenation Is, and What Sexual Longevity Means
Sex started to hurt. Lubricant helped for an hour, then stopped helping. You were told your bloodwork was normal, or that this is part of getting older. Many women hear some version of that before anyone examines the tissue itself.
Here is what is usually going on. When estrogen and androgen levels fall, the lining of the vagina thins, produces less moisture, loses elasticity and gets less blood flow. The clinical name is genitourinary syndrome of menopause (GSM). It also affects the bladder and urethra, which is why urgency and repeat urinary infections often show up alongside dryness.
Non-surgical vaginal rejuvenation is the group of in-office treatments that act on that tissue directly: no incisions, no general anesthesia and no ablative laser. Most sessions take under an hour.
Sexual longevity is the wider idea behind it. It means keeping sexual function, genital tissue and the hormones that govern them healthy across your whole life, and treating changes as ongoing medical care instead of something that simply ends. A woman can live 30 or more years after menopause. The tissue that changes first deserves the same attention as her heart and bones.
This is for you if you have:
Pain, burning or tearing during or after sex
Dryness that lubricants and moisturizers no longer fix
Desire or arousal that dropped, especially suddenly or after surgery
Reduced sensation or muted orgasm
Laxity or loss of tone after childbirth or with age
Urinary urgency or infections that keep coming back
Symptoms during or after breast cancer treatment, when systemic hormones are off the table
Age alone does not decide who benefits. Tissue quality and hormone levels do, and both can be measured.
Why Women Seek Treatment
Painful sex that started gradually
Pain with intercourse, called dyspareunia, often creeps in slowly. Many women adjust around it for years before naming it. Common is not the same as untreatable. The thinning that causes friction pain is a physical change in the tissue, and physical treatments act on it. RFC's page on vaginal PRP and sexual health explains the procedure in more detail.
Dryness that lubricant can't fix
Lubricant changes the friction. It doesn't change the tissue. When the epithelium (the surface layer of cells) is thin, it produces less moisture on its own. Treatments that increase blood flow and support tissue repair aim at the cause, not the symptom of the moment.
Desire that disappeared
Low desire is sometimes psychological or relational. Often it isn't. Testosterone and DHEA levels fall with age, and with surgical menopause they fall abruptly. Many routine panels don't include free testosterone, DHEA-S or SHBG, the three markers most tied to desire. That is how women get told their results are normal when the relevant numbers were never checked. If hot flashes and sleep problems are part of the picture too, RFC also treats hot flashes.
After breast cancer
Aromatase inhibitors and other estrogen-blocking drugs cause severe dryness and painful sex. Systemic hormones are usually ruled out, and many women are offered little beyond a moisturizer. Several non-surgical options work locally and don't add systemic hormones, which is why this group has the most to gain from them.
The Treatments, One by One
At Velva, the sexual longevity practice founded by the same physician who founded RFC, a board-certified physician performs every treatment. Not a nurse injector, not a technician. You can read about the physicians behind both practices on RFC's providers page. Care starts with testing, not a procedure menu.
1. Vaginal PRP (platelet-rich plasma)
What it is: A small blood draw is spun in a centrifuge to concentrate your platelets, which carry growth factors involved in tissue repair. The PRP is then placed at several sites in the vaginal wall under local anesthetic.
Time: About an hour, in the office.
Used for: Painful sex, dryness and thinning, reduced sensation.
Note: This is the same general approach many clinics market as the O-Shot, a trademarked name.
More detail: vaginal PRP at Velva.
2. Adipose-derived PRP
What it is: A small amount of your own fat is harvested under local anesthesia, processed with its stromal vascular fraction intact, combined with PRP and placed to restore structural volume.
Used for: Laxity and loss of structural tone and firmness.
Who can't have it: Women with hormone-receptor-positive breast cancer, because fat tissue produces estrogen locally.
Risk to know: Fat embolism after fat grafting to the genital area is rare and serious. That is why a physician performs it, and why candidacy is assessed individually and often declined.
Honest label: Because it includes a fat harvest, this is the one option here that counts as a minor procedure rather than an injection or a session.
More detail: adipose-derived PRP.
3. GigaLaser red and near-infrared light
What it is: 660 nm red and 808 nm near-infrared light delivered across the lower abdomen. You stay fully clothed. Roughly 20 minutes, no downtime.
Used for: Supporting blood flow and tissue health, usually alongside PRP or ozone.
Course: Six sessions, three a week for two weeks.
RFC's GigaLaser red light therapy page covers the device.
4. Medical ozone
What it is: Medical-grade ozone delivered to the tissue through a soft applicator. No needles, no anesthetic, 15 to 20 minutes.
Used for: A supportive, non-hormonal option, most often as a six-session course when infections keep returning.
Regulatory status: Medical ozone is not FDA-approved for vaginal or pelvic use. You should hear that from any clinic offering it.
RFC also offers whole-body ozone sauna therapy. Velva's pelvic ozone and red light page covers the pelvic protocol.
What the Research Shows: Non-Surgical Vaginal Rejuvenation Outcomes
The evidence for non-surgical vaginal rejuvenation is newer than the evidence for estrogen, and it is still growing. Here is what the strongest recent studies found, including who was in them.
Vaginal PRP, randomized trial. A 2026 randomized, placebo-controlled trial in Obstetrics & Gynecology (Clarke et al.) gave 52 women a single PRP or saline injection into the front vaginal wall. At six months, 69.2% of the PRP group reported improved sexual function, compared with 34.6% on placebo. That is the strongest controlled evidence for vaginal PRP to date. The participants were premenopausal women aged 18 to 50 without severe sexual dysfunction, so trials in postmenopausal women are still needed.
Vaginal PRP after breast cancer. A 2025 pilot study in Obstetrics & Gynecology treated 20 breast cancer survivors with GSM using a single PRP treatment, including women on aromatase inhibitors. At six months, 95% reported their symptoms had improved, and sexual function, urinary symptoms and quality of life scores all improved. Side effects such as spotting or mild cramping resolved within 24 hours, with no serious adverse events. There was no placebo group, and a controlled trial is planned.
Red light (photobiomodulation). A 2026 prospective study in PLOS ONE (Wu et al.) gave 27 postmenopausal women eight weekly sessions of 660 nm light. Three months after treatment, every participant's tissue scored in the non-atrophic range on the Vaginal Health Index, urinary symptom scores improved, and no adverse events occurred. One distinction matters: that study delivered light through an intravaginal probe. GigaLaser is delivered through the lower abdomen, so those results can't be assumed to transfer.
Testosterone for low desire. The Global Consensus Position Statement on Testosterone Therapy for Women (Davis et al., Journal of Clinical Endocrinology & Metabolism, 2019), endorsed by 11 medical societies, concluded that HSDD in postmenopausal women is the one evidence-based reason to prescribe testosterone to women. It advises doses that restore premenopausal levels, not higher, and recommends against compounded products.
Treatment | Study | Who was studied | Key result | Limit to know |
Vaginal PRP | Randomized, placebo-controlled (2026) | 52 premenopausal women, 18–50 | 69.2% improved vs. 34.6% placebo at 6 months | Premenopausal only; single center |
Vaginal PRP | Pilot, no control group (2025) | 20 breast cancer survivors with GSM | 95% reported improvement at 6 months | Small, uncontrolled |
Red light, 660 nm | Prospective, single arm (2026) | 27 postmenopausal women, mean age 62.9 | 100% reached non-atrophic tissue score at 3 months | Intravaginal probe; no control group |
Testosterone | Global consensus statement (2019) | Meta-analyses of randomized trials | Supported for HSDD after menopause | Not supported for other uses |
Which Treatment for Which Symptom, Including After Breast Cancer
Most articles on non-surgical vaginal rejuvenation list treatments. Few match them to symptoms, and almost none say which are safe after breast cancer. This table does both.
Symptom | Primary treatment | Supporting | After hormone-receptor-positive breast cancer |
Pain with sex | Vaginal PRP | Local estrogen if safe, ozone, red light | Vaginal PRP, ozone, red light available |
Dryness and thinning | Local estrogen or vaginal PRP | Ozone, red light | Vaginal PRP, ozone, red light available |
Reduced sensation or orgasm | Vaginal PRP | Red light, hormones if indicated | Vaginal PRP, red light available |
Low desire | Hormone testing, then testosterone if HSDD is confirmed | Treat any pain first | Coordinate with your oncologist |
Recurrent UTIs, urgency | Microbiome assessment | Local estrogen if safe, ozone | Ozone available |
Laxity, loss of tone | Adipose-derived PRP | Red light | Adipose-derived PRP not offered |
Three points from that table stand out. First, PRP, ozone and red light all act locally and add no systemic hormones, so most women who have finished or are still on breast cancer treatment have real options. Second, adipose-derived PRP is the exception, because fat tissue makes estrogen. Third, a good clinic coordinates with your oncologist and does not prescribe against their guidance.
Non-Surgical vs. Surgical Vaginal Rejuvenation: How to Decide
Non-surgical vaginal rejuvenation
Targets the tissue: thickness, moisture, blood flow, elasticity
In-office, local anesthetic at most, little or no downtime
Built for dryness, painful sex, reduced sensation and urinary symptoms
Often staged over several sessions, with maintenance as tissue keeps aging
Several options suit women after breast cancer
Surgical vaginal rejuvenation (vaginoplasty, labiaplasty)
Changes structure by removing or tightening tissue
Operating room, longer recovery, surgical risks
Built for anatomical changes such as significant prolapse or structural damage after childbirth
Does not treat thin, dry tissue or low hormones
The right choice depends on what is actually wrong. If the problem is tissue quality, which covers most menopause-related symptoms, surgery does not fix it. If the problem is structural, tissue treatments alone won't either. An exam answers that question in one visit. Velva does not offer surgery, CO2 laser resurfacing, vaginoplasty or labiaplasty.
Vaginal Rejuvenation Price, Timeline and Next Steps
Most practices in New York don't publish prices, or post them as images search engines can't read. Velva publishes every vaginal rejuvenation price on its pricing page. Prices below are from that page as of October 2026 and may change.
Service | Single | Course | Time and downtime | Where |
New patient consultation | $450 | Follow-up $350 | Virtual or in person | New Rochelle or virtual |
Hormone panel | $800 | Repeat panel $500 | Blood draw | New Rochelle |
Vaginal PRP | $2,200 | 3 sessions $5,700 | About 1 hour, local anesthetic | New Rochelle, Westport CT, Jericho |
Adipose-derived PRP | $8,500 | — | Fat harvest under local anesthetic | New Rochelle, Westport CT, Jericho |
GigaLaser red light | $100 | 6 sessions $550 | About 20 minutes, none | Manhattan only |
Medical ozone | $200 | 6 sessions $950 | 15–20 minutes, none | Manhattan, Westport CT, Jericho |
Tests to ask for first:
Estradiol
Total and free testosterone
DHEA-S
SHBG (sex hormone-binding globulin)
Thyroid function, if fatigue or low desire is part of the picture
Questions to ask any provider:
Who performs the treatment: a physician, or a nurse or technician?
What does my exam show about tissue thickness and pH?
Which treatment fits my symptoms, and why that one?
What does the evidence show, and in which patients was it studied?
Is this safe with my cancer history or current medications?
What the first one to three months look like:
Week 1: Consultation, exam and hormone panel. Bring recent bloodwork.
Weeks 2–3: Results reviewed and a plan set. Light or ozone courses can start right away.
First PRP session: About an hour in the office, with a follow-up review included.
Weeks 6–12: Reassessment. A three-session PRP course is scheduled around your response, not a fixed calendar.
Velva sees patients in New Rochelle, Manhattan, Westport and Jericho. RFC's locations page has directions and travel information for the same offices.
Frequently Asked Questions
What is non-surgical vaginal rejuvenation?
Non-surgical vaginal rejuvenation is in-office treatment for thin, dry, painful or lax vaginal tissue without incisions or ablative lasers. Options include vaginal PRP, red and near-infrared light, medical ozone and hormone therapy guided by testing. Most sessions take under an hour with little or no downtime.
How much does vaginal rejuvenation cost?
At Velva, vaginal PRP is $2,200 per session or $5,700 for three. Red light starts at $100, medical ozone at $200, and adipose-derived PRP is $8,500. A new patient consultation is $450 and the hormone panel is $800. Insurance is not billed; HSA and FSA funds generally apply.
Can I have vaginal rejuvenation after breast cancer?
Usually, yes. Vaginal PRP, medical ozone and red light work locally and add no systemic hormones. A 2025 pilot study found 95% of breast cancer survivors reported improvement after one PRP treatment. Adipose-derived PRP is not offered after hormone-receptor-positive breast cancer.
Does red light therapy help vaginal dryness?
A 2026 study of 27 postmenopausal women found 660 nm light restored non-atrophic tissue scores in every participant at three months. That study used an intravaginal probe. GigaLaser is delivered through the lower abdomen and is usually used to support PRP or ozone.
Is vaginal PRP the same as the O-Shot?
It is the same general approach: your own platelet-rich plasma placed in the vaginal wall. "O-Shot" is a trademarked name some clinics use under license. What matters more is who performs it, how the PRP is prepared and whether you were examined and tested first.
The Bottom Line
Dryness, painful sex, low desire and laxity are medical problems with measurable causes. Non-surgical vaginal rejuvenation treats the tissue itself, starting with testing, and several options remain open after breast cancer. The evidence is newer than for estrogen, it is growing, and a good clinic will tell you exactly what it shows.
RFC's founding physician also leads Velva, a practice devoted entirely to women's sexual longevity, where every treatment is performed by a physician and every price is published. To start with an exam and a hormone panel, apply for a Velva consultation.
